HOLLAND & KNIGHT LLP for AMERICAN MEDICAL TECHNOLOGISTS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Payment and reimbursement for Medicare clinical laboratory testing; Medicare Part B reimbursement policies; Adjustments to Medicare Clinical Laboratory Fee Schedule; Affordable Care Act implementation; Repeal of the Affordable Care Act's excise tax on medical devices; Implementation of Sec. 216 of the Protecting Access to Medicare Act (PAMA) of 2014.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL N MCCARTY | — |
Medical/Disease Research/Clinical Labs MED
Payment and reimbursement for Medicare clinical laboratory testing; Medicare Part B reimbursement policies; Adjustments to Medicare Clinical Laboratory Fee Schedule; Affordable Care Act implementation; Repeal of the Affordable Care Act's excise tax on medical devices; Regulation of laboratory-developed tests as medical devices by the Food and Drug Administration.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL N MCCARTY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.